fda bpc-157 not approved warning 2024 2025 Regulatory Alert: FDA's April 2026 Update on and GHK-Cu – Holt Law The peptide, the fitness world

Gomberg SJ, Wustrack RL, Napoli N, Arnaud CD, Black DM

Marissa Liza: Exactly

AOD9604 vs Intact hGH in Obesity Models A direct head-to-head comparison of AOD9604 and intact hGH in obese and lean mice confirmed that both compounds significantly reduced body weight gain in obese animals through increased fat oxidation and lipolysis stimulation but that AOD9604 achieved this without the hGH receptor binding, IGF-1 stimulation, hyperglycaemia, or reduced insulin secretion associated with full-length hGH treatment

At Vitality Health SFL, we see first hand how well these targeted therapies can help our clients get back on their feet faster

Metabolic health improvements Beyond the scale, cagrilintide produces measurable improvements in metabolic biomarkers that predict long-term health outcomes